5-AMINO-1MQ 50MG X 50 TABLETS: CELLULAR ENERGY EFFICIENCY AND METABOLIC REGULATION

Description

Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. 5-Amino-1MQ is not approved for medical use, human consumption, or as a therapeutic treatment in this context.

Product Details

• Total Quantity: 50mg per tablet. 50 tablets per bottle

• Form: Oral research tablets

• Delivery Format: Solid oral dosage form for laboratory analysis

• Packaging: Secure, sealed, tamper-evident container

• Source: High-purity laboratory-grade compound, independently third-party tested

• Purity: ≥98% verified via analytical testing

• Note: Intended strictly for controlled laboratory and experimental research applications

Overview of 5-Amino-1MQ’s Research Profile

5-Amino-1MQ is a small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor studied in research settings for its role in cellular energy regulation, methylation balance, and metabolic signaling pathways. NNMT is an enzyme involved in nicotinamide metabolism and methyl-donor utilization, making it a point of interest in studies examining cellular energy efficiency and metabolic regulation.

In laboratory environments, 5-Amino-1MQ is utilized to investigate how NNMT inhibition influences intracellular NAD⁺ availability, methylation dynamics, and downstream metabolic signaling. Its oral tablet format allows researchers to explore compound stability, absorption modeling, and delivery consistency in non-clinical experimental frameworks.

Research Specifics

5-Amino-1MQ has been examined in non-clinical research for its involvement in:

• NNMT Inhibition Studies
  Modeling suppression of nicotinamide N-methyltransferase activity and its metabolic consequences.

• NAD⁺ Pathway Research
  Investigating interactions between NNMT activity, nicotinamide metabolism, and cellular energy systems.

• Methylation Balance Analysis
  Exploring how NNMT modulation affects methyl-donor utilization and biochemical equilibrium.

• Metabolic Signaling Pathway Modeling
  Studying downstream effects related to energy expenditure, lipid metabolism signaling, and cellular efficiency.

• Oral Delivery & Stability Research
  Evaluating compound integrity and consistency in solid oral dosage forms under experimental conditions.

Key Features

• Compound Class: Small-molecule NNMT inhibitor

• Form: Oral research tablets

• Total Content: 50mg x 50 tablets

• Purity: ≥98% research-grade

• Laboratory Stability: Designed for reliable performance when stored under recommended conditions

Potential Applications

Researchers may explore 5-Amino-1MQ in studies involving:

• NNMT enzyme activity and inhibition models

• NAD⁺ metabolism and energy regulation pathways

• Methylation and metabolic efficiency research

• Small-molecule metabolic signaling analysis

• Oral compound formulation and stability studies

Specifications

This product is supplied in a sealed, tamper-evident container to preserve compound integrity and purity. Tablets should be stored in a cool, dry environment according to standard laboratory handling protocols for small-molecule research compounds.